195196-07-7 Usage
Uses
Used in Pharmaceutical Industry:
TERT-BUTYL 2-OXO-3-(TRIFLUOROMETHYL)PIPERIDIN-3-YLCARBAMATE is used as a pharmaceutical intermediate for its role in the synthesis of new drugs for various medical conditions. Its unique chemical structure, including the piperidine ring and the trifluoromethyl group, makes it a valuable component in the development of innovative pharmaceuticals.
Used in Drug Discovery and Development:
In the field of drug discovery and development, TERT-BUTYL 2-OXO-3-(TRIFLUOROMETHYL)PIPERIDIN-3-YLCARBAMATE serves as a key building block. Its presence in the molecular structure of potential drug candidates can influence their pharmacological properties, such as potency, selectivity, and metabolic stability, thereby contributing to the advancement of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 195196-07-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,5,1,9 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 195196-07:
(8*1)+(7*9)+(6*5)+(5*1)+(4*9)+(3*6)+(2*0)+(1*7)=167
167 % 10 = 7
So 195196-07-7 is a valid CAS Registry Number.
195196-07-7Relevant academic research and scientific papers
Osipov, Sergej N.,Tsouker, Pavel,Hennig, Lothar,Burger, Klaus
, p. 271 - 274 (2004)
Syntheses of racemic 3-trifluoromethyl- and 3-difluoromethyl-thalidomide starting from 2-(tert-butyloxycarbonylimino)-3,3,3-trifluoropropionate or -3,3-difluoropropionate as fluorine-containing building blocks are described.
TYK2 INHIBITORS AND USES THEREOF
-
, (2017/03/21)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
New efficient syntheses of α-difluoromethyl- and α-trifluoromethyl-ornithine
Osipov, Sergey N.,Golubev, Alexander S.,Sewald, Norbert,Burger, Klaus
, p. 5965 - 5966 (2007/10/03)
A new efficient method for the preparation of ornithine derivatives 3-5 is described. The key step of the synthesis is the regioselective alkylation of imine 2 with propargyl amine 1.
